Gene · 9582
Papers1,875
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
101 to 120 of 1,875
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The cytidine deaminase APOBEC3C has unique sequence and genome feature preferences. | Genetics | 2024 | 38946641 | PubTator, text mining | PubMed |
| APOBEC3-related mutations in the spike protein-encoding region facilitate SARS-CoV-2 evolution. | Heliyon | 2024 | 38868014 | PubTator, text mining | PubMed |
| New insights into ATR inhibition in muscle invasive bladder cancer: The role of apolipoprotein B mRNA editing catalytic subunit 3B. | Oncol Res | 2024 | 38827321 | PubTator, text mining | PubMed |
| Nuclear actin structure regulates chromatin accessibility. | Nat Commun | 2024 | 38750021 | PubTator, text mining | PubMed |
| Development of Allosteric Small Molecule APOBEC3B Inhibitors from In Silico Screening. | bioRxiv | 2024 | 38712210 | PubTator, text mining | PubMed |
| Functional genomics identifies N-acetyllactosamine extension of complex N-glycans as a mechanism to evade lysis by natural killer cells. | Cell Rep | 2024 | 38619967 | PubTator, text mining | PubMed |
| Protein Interaction Map of APOBEC3 Enzyme Family Reveals Deamination-Independent Role in Cellular Function. | Mol Cell Proteomics | 2024 | 38548018 | PubTator, text mining | PubMed |
| Persistence of collective memory of corporate bankruptcy events discussed on X (Twitter) is influenced by pre-bankruptcy public attention. | Sci Rep | 2024 | 38503803 | PubTator, text mining | PubMed |
| Distinguishing preferences of human APOBEC3A and APOBEC3B for cytosines in hairpin loops, and reflection of these preferences in APOBEC-signature cancer genome mutations. | Nat Commun | 2024 | 38499553 | PubTator, text mining | PubMed |
| Mesoscale DNA features impact APOBEC3A and APOBEC3B deaminase activity and shape tumor mutational landscapes. | Nat Commun | 2024 | 38499542 | PubTator, text mining | PubMed |
| Differentiation signals induce APOBEC3A expression via GRHL3 in squamous epithelia and squamous cell carcinoma. | Res Sq | 2024 | 38496447 | PubTator, text mining | PubMed |
| Observing Dynamic Conformational Changes within the Coiled-Coil Domain of Different Laminin Isoforms Using High-Speed Atomic Force Microscopy. | Int J Mol Sci | 2024 | 38396630 | PubTator, text mining | PubMed |
| Monitoring APOBEC3A protein levels in human cancer cells. | Methods Cell Biol | 2024 | 38359985 | PubTator, text mining | PubMed |
| Role and molecular mechanism of APOBEC3B in the development and progression of gastric cancer. | Heliyon | 2024 | 38312680 | PubTator, text mining | PubMed |
| Stage II oesophageal carcinoma: peril in disguise associated with cellular reprogramming and oncogenesis regulated by pseudogenes. | BMC Genomics | 2024 | 38308202 | PubTator, text mining | PubMed |
| Large overlap in neutrophil transcriptome between lupus and COVID-19 with limited lupus-specific gene expression. | Lupus Sci Med | 2024 | 38302132 | PubTator, text mining | PubMed |
| DEEPOMICS FFPE, a deep neural network model, identifies DNA sequencing artifacts from formalin fixed paraffin embedded tissue with high accuracy. | Sci Rep | 2024 | 38297116 | PubTator, text mining | PubMed |
| Mapping the landscape of HPV integration and characterising virus and host genome interactions in HPV-positive oropharyngeal squamous cell carcinoma. | Clin Transl Med | 2024 | 38279874 | PubTator, text mining | PubMed |
| Microbiome and Prostate Cancer: Emerging Diagnostic and Therapeutic Opportunities. | Pharmaceuticals (Basel) | 2024 | 38256945 | PubTator, text mining | PubMed |
| APOBEC Mutagenesis in Cancer Development and Susceptibility. | Cancers (Basel) | 2024 | 38254863 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/9582/papers?page=6